A phase 2 b study to evaluate the safety and efficacy of XG005 tablets in Chinese patients with knee osteoarthritis
Latest Information Update: 24 Jan 2025
Price :
$35 *
At a glance
- Drugs Naproxen/pregabalin (Primary)
- Indications Pain
- Focus Therapeutic Use
- 22 Jan 2025 Results (n=318) evaluating the safety and efficacy of of XG005 presented in the ACR Convergence 2024.
- 03 Jan 2025 New trial record